ERJ
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Permissions
Right arrowRequest Permissions
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (11)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Viegi, G.
Right arrow Articles by Carrozzi, L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Viegi, G.
Right arrow Articles by Carrozzi, L.
Eur Respir J 2007; 30:993-1013
Copyright ©ERS Journals Ltd 2007

Definition, epidemiology and natural history of COPD

G. Viegi1, F. Pistelli1,2, D. L. Sherrill1,3, S. Maio1, S. Baldacci1 and L. Carrozzi1,2

1 Pulmonary Environmental Epidemiology Unit, CNR Institute of Clinical Physiology, and 2 Cardiothoracic Dept, University of Pisa, Pisa, Italy, 3 Arizona Clinical Research Training Program, Mel and Enid Zuckerman College of Public Health, University of Arizona, Tucson, AZ, USA.

CORRESPONDENCE: G. Viegi, CNR Institute of Clinical Physiology, Via Trieste 41, 56126 Pisa, Italy. Fax: 39 050502031. E-mail: viegig{at}ifc.cnr.it

Keywords: Air pollution, chronic obstructive pulmonary disease clinical/basic investigations, cor pulmonale, epidemiology of asthma/chronic obstructive pulmonary disease, smoking, spirometry

Received: July 4, 2007
Accepted August 13, 2007

Chronic obstructive pulmonary disease (COPD) is the fifth cause of morbidity and mortality in the developed world and represents a substantial economic and social burden. Patients experience a progressive deterioration up to end-stage COPD, characterised by very severe airflow limitation, severely limited and declining performance status with chronic respiratory failure, advanced age, multiple comorbidities and severe systemic manifestations/complications.

COPD is frequently underdiagnosed and under-treated. Today, COPD develops earlier in life and is less gender specific. Tobacco smoking is the major risk factor for COPD, followed by occupation and air pollution. Severe deficiency for {alpha}1-antitrypsin is rare; several phenotypes are being associated with elevated risk for COPD in the presence of risk factor exposure. Any patient presenting with cough, sputum production or dyspnoea should be assessed by standardised spirometry. Continued exposure to noxious agents promotes a more rapid decline in lung function and increases the risk for repeated exacerbations, eventually leading to end-stage disease.

Without major efforts in prevention, there will be an increasing proportion of end-stage patients who can live longer through long-term oxygen therapy and assisted ventilation, but with elevated suffering and huge costs. Smoking prevention and smoking cessation are the most important epidemiological measurements to counteract chronic obstructive pulmonary disease epidemics.




This article has been cited by other articles:


Home page
 Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
J. A. Poole, G. M. Thiele, N. E. Alexis, A. M. Burrell, C. Parks, and D. J. Romberger
Organic dust exposure alters monocyte-derived dendritic cell differentiation and maturation
Am J Physiol Lung Cell Mol Physiol, October 1, 2009; 297(4): L767 - L776.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
P-O. Bridevaux, M. W. Gerbase, C. Schindler, D. Felber Dietrich, I. Curjuric, J. Dratva, U. Ackermann-Liebrich, N. M. Probst-Hensch, J-M. Gaspoz, and T. Rochat
Sex-specific effect of body weight gain on systemic inflammation in subjects with COPD: results from the SAPALDIA cohort study 2
Eur. Respir. J., August 1, 2009; 34(2): 332 - 339.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
O. Laurent, G. Pedrono, L. Filleul, C. Segala, A. Lefranc, C. Schillinger, E. Riviere, and D. Bard
Influence of Socioeconomic Deprivation on the Relation Between Air Pollution and {beta}-Agonist Sales for Asthma
Chest, March 1, 2009; 135(3): 717 - 723.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
P. Michelozzi, G. Accetta, M. De Sario, D. D'Ippoliti, C. Marino, M. Baccini, A. Biggeri, H. R. Anderson, K. Katsouyanni, F. Ballester, et al.
High Temperature and Hospitalizations for Cardiovascular and Respiratory Causes in 12 European Cities
Am. J. Respir. Crit. Care Med., March 1, 2009; 179(5): 383 - 389.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
A. Chaouat, R. Naeije, and E. Weitzenblum
Pulmonary hypertension in COPD
Eur. Respir. J., November 1, 2008; 32(5): 1371 - 1385.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
J. Vestbo, W. Anderson, H. O. Coxson, C. Crim, F. Dawber, L. Edwards, G. Hagan, K. Knobil, D. A. Lomas, W. MacNee, et al.
Evaluation of COPD Longitudinally to Identify Predictive Surrogate End-points (ECLIPSE)
Eur. Respir. J., April 1, 2008; 31(4): 869 - 873.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2007 by the European Respiratory Society.